Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 61 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
601 16.2 months Malignant pleural mesothelioma 4 Chemotherapy
Sotiria General Hospital Greece 2/2011
Treatment Details: Patients: This study involved 37 patients with malignant pleural mesothelioma. The median age of the group was 66 years and 81.1% were male. Treatment: Patients were treated with a com
 
602 16.2 months Advanced urothelial carcinoma 4 Chemotherapy
Japanese Foundation of Cancer Research Japan 4/2013
Treatment Details: Patients: This study involved 42 advanced urothelial carcinoma patients who had not been previously treated with chemotherapy. The median patient age was 64 years and 54.8% were male. T
 
603 16.1 months Platinum resistant ovarian cancer and primary peritoneal carcinoma 4 Biologic therapy
Chemotherapy
Mayo Clinic United States 6/2012
Treatment Details: Patients: This phase II study involved 40 women with platinum-resistant ovarian and primary peritoneal carcinoma. The median patient age was 59 years. Treatment: Patients were treated
 
604 16.1 months Castration-Resistant Prostate Cancer 5 Radiation
Mount Vernon Cancer Centre United Kingdom 11/2014
Treatment Details: Patients: This phase 3 study involved castration-resistant prostate cancer patients with bone metastases who were divided into two groups based on prior treatment. Group A had 352 patients
 
605 16.1 months GBM 4 Biologic therapy
Chemotherapy
Radiation
Centre Hospitalier Universitaire Vaudois Switzerland 6/2010
Treatment Details: Patients: This study involved 52 patients with newly diagnosed glioblastoma. The median age of the patients was 57 years and 62% were male. Patients had not received prior chemotherapy or
 
606 16.1 months Metastatic colorectal cancer 4 Chemotherapy
Haukeland University Hospital Norway 1/2004
Treatment Details: Patients: This Phase II study involved 85 patients with metastatic colorectal cancer. Treatment: The treatment consisted of three chemotherapy drugs oxaliplatin (eloxatin), fluorouraci
 
607 16.1 months Metastatic colorectal cancer 4 Chemotherapy
Haukeland University Hospital Norway 1/2004
Treatment Details: Patients: This Phase II study involved 85 patients with metastatic colorectal cancer. Treatment: The treatment consisted of three chemotherapy drugs oxaliplatin (eloxatin), fluorouraci
 
608 16.0 months Advanced colorectal cancer 4 Chemotherapy
Vienna University Medical School Austria 1/2002
Treatment Details: Patients: This Phase II study involved 92 patients with previously untreated advanced colorectal cancer. Forty-six patients were randomized to group A (arm A) and forty-six patients were r
 
609 16.0 months Advanced breast cancer 4 Chemotherapy
U.S. Oncology, Inc United States 9/2002
Treatment Details: Patients: This Phase II trial involved 100 patients with advanced breast cancer. Treatment: The treatment consisted of two chemotherapy drugs paclitaxel (taxol) and carboplatin (parapla
 
610 16.0 months Newly diagnosed advanced colorectal cancer 4 Chemotherapy
Vienna University Medical School Austria 1/2002
Treatment Details: Patients: This Phase II study involved 92 patients with previously untreated advanced colorectal cancer. Forty-six patients were randomized to group A (arm A) and forty-six patients were r
 
Page 61 of 187  | Previous Page  | Next Page